Image de couverture de livre

Coronary Calcium Scoring in Diabetes: Recalibrating Cardiovascular Risk in 2025

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Kyvan Irannejad, Matthew Budoff
Format:	Artículo Open Access
Publié:	Wiley 2025
Sujets:	Journal of Diabetes
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Comparative Analysis of AI Tools for Disseminating ADA 2025 Diabetes Care Standards: Implications for Cardiovascular Physicians
par: Tengfei Zheng
Publié: (2025)

Overcoming Missing Data: Accurately Predicting Cardiovascular Risk in Type 2 Diabetes, A Systematic Review
par: Wenhui Ren, et autres
Publié: (2025)

Bidirectional Mediation and Synergistic Mortality Risks in Diabetes and Cardiovascular Disease: Evidence From NHANES 2005–2018
par: Zixuan Li, et autres
Publié: (2025)

Association of Geriatric Nutritional Risk Index With Cardiovascular and All‐Cause Mortality Among US Elderly Adults With Diabetic Nephropathy
par: Chun Sun, et autres
Publié: (2025)

Cardiovascular Therapy Benefits of Novel Antidiabetic Drugs in Patients With Type 2 Diabetes Mellitus Complicated With Cardiovascular Disease: A Network Meta‐Analysis
par: Saixian Shi, et autres
Publié: (2025)

Cardiovascular Disease, Cancer and Dementia in Diabetes: 20‐Year Trends Will Necessitate New Treatment Priorities
par: Zachary T. Bloomgarden
Publié: (2026)

Healthy Sleep Behaviors Reduce the Risk of Microvascular and Cardiovascular Complications in Patients With Type 2 Diabetes and Are Associated With Potential Serum Biomarkers: A UK Biobank Observational Cohort Study
par: Rui Lan, et autres
Publié: (2025)

Diabetes Status Modifies the Association Between Cardiorespiratory Fitness and Coronary Heart Disease: A Cross‐Sectional Study
par: Li Wang, et autres
Publié: (2025)

The Diabetic Cognitive Impairment Score for Early Screening of Cognitive Impairment in Type 2 Diabetes Patients
par: Shujun Zhang, et autres
Publié: (2025)

Effect of Glucagon‐Like Peptide‐1 Receptor Agonists on Renal and Cardiovascular Risk Factors in Patients With Type 2 Diabetes Mellitus: A Retrospective Study
par: Daniel Yuan, et autres
Publié: (2025)

Elevated Uric Acid/Albumin Ratio Predicts Poor Coronary Collateral Circulation in Type 2 Diabetic Patients With Stable Coronary Artery Disease
par: Lin Shuang Mao, et autres
Publié: (2025)

Iron‐Deficiency Anemia Elevates Risk of Diabetic Kidney Disease in Type 2 Diabetes Mellitus
par: Bin Huang, et autres
Publié: (2025)

Predictive value of Systematic Coronary Risk Evaluation 2‐Diabetes risk model and arterial stiffness for cardiovascular events in the Asian population with type 2 diabetes mellitus
par: Pannipa Suwannasom, et autres
Publié: (2024)

Correction to “Iron‐Deficiency Anemia Elevates Risk of Diabetic Kidney Disease in Type 2 Diabetes Mellitus”
Publié: (2025)

Indobufen Versus Aspirin Plus Clopidogrel in Patients After Coronary Stenting in Patients With Diabetes: A Post Hoc Analysis of the OPTION Trial
par: Shujing Wu, et autres
Publié: (2025)

Comment on “Time Trends in Cardiovascular Event Incidence in New‐Onset Type 2 Diabetes: A Population‐Based Cohort Study From Germany”
par: Saraswati Sah, et autres
Publié: (2025)

Risk Factors for Diabetic Retinopathy Change With Diabetes Duration: Synergistic Effect of Long Duration and Anemia
par: Yuan Liu, et autres
Publié: (2026)

November 11–12, 2025, T1DX‐QI Learning Session, Journal of Diabetes
Publié: (2026)

Author Response to the Comment on “Time Trends in Cardiovascular Event Incidence in New‐Onset Type 2 Diabetes: A Population‐Based Cohort Study From Germany”
par: Theresia Sarabhai, et autres
Publié: (2025)

No Evidence of Metabolomic Disruptions From Real‐World Intakes of Aspartame or Saccharin: The Coronary Artery Risk Development in Young Adults Study
par: Brian T. Steffen, et autres
Publié: (2025)

First‐Degree Family History of Diabetes Is Associated With the Presence of Depressive Symptoms Independent of Lifestyle Risk Factors and Cardiometabolic Risk Factors
par: Mengying Chen, et autres
Publié: (2025)

Efficacy of GLP‐1 Receptor Agonist‐Based Therapies on Cardiovascular Events and Cardiometabolic Parameters in Obese Individuals Without Diabetes: A Meta‐Analysis of Randomized Controlled Trials
par: Yue Yin, et autres
Publié: (2025)

The Effect of Canagliflozin Dose on Renal and Cardiovascular Outcomes in Type 2 Diabetes and High Cardiovascular Risk
par: Elias John Elenjickal, et autres
Publié: (2026)

Diabetes Complications and Comorbidities as Risk Factors for MACE in People With Type 2 Diabetes and Their Development Over Time: A Danish Registry‐Based Case–Control Study
par: Asger Ahlmann Bech, et autres
Publié: (2025)

Commentary on “Pedal Medial Arterial Calcification in Diabetic Foot Ulcers: A Significant Risk Factor of Amputation and Mortality”
par: Mostafa Javanian, et autres
Publié: (2025)

Non‐Traditional Lipid Parameters and Risk of Adverse Pregnancy Outcomes in Gestational Diabetes Mellitus: Mediation by Maternal Metabolites
par: Jing‐yi Guo, et autres
Publié: (2025)

Risk Factors for the Progression or Regression to Diabetes or Normoglycaemia for Men with Impaired Fasting Glucose
par: Jacob W. Harland, et autres
Publié: (2025)

Vitamin C Alleviates the Risk of Gestational Diabetes Mellitus Associated With Exposure to Metals
par: Ying Wang, et autres
Publié: (2024)

Plantar Tissue Characteristics in People With Diabetes With and Without Peripheral Neuropathy: A Novel Explanatory Model for DPN Risk Assessment
par: Yiming Li, et autres
Publié: (2025)

Sleep Phenotypes, Genetic Susceptibility, and Risk of Obesity in Patients With Type 2 Diabetes: A National Prospective Cohort Study
par: Lei Xi, et autres
Publié: (2025)

Physical Activity and Cardiovascular Health
par: Alexander Polyak, et autres
Publié: (2026)

Response to Commentary on “Sleep Phenotypes, Genetic Susceptibility, and Risk of Obesity in Patients With Type 2 Diabetes: A National Prospective Cohort Study”
par: Lei Xi, et autres
Publié: (2025)

Socioeconomic Status, Modifiable Factors, and Risk of Microvascular Complications in Individuals With Type 2 Diabetes: A Cohort Study From the UK Biobank
par: Ying Li, et autres
Publié: (2025)

Ketogenic Diet, Serum Ketone Bodies and Risk of End‐Stage Renal Disease in Patients With Diabetic Kidney Disease: A Multi‐Cohort Study
par: Ke Liu, et autres
Publié: (2025)

Diabetic Kidney Disease Update
par: Christian Mende, et autres
Publié: (2025)

A Review of Emerging Biomarkers Connecting Diabetes and Ischemic Stroke: Implications for Early Detection and Risk Stratification
par: Nadia Hussain, et autres
Publié: (2026)

Risk Factors and Pregnancy Outcomes of Twin Pregnancies With Gestational Diabetes Mellitus: A Comparison Based on Chorionicity
par: Shuai Huang, et autres
Publié: (2026)

Polygenic Risk Score Predicts Prostate Cancer Risk Independent of Type 2 Diabetes
par: Guk Jin Lee, et autres
Publié: (2026)

Predictive Capability of Dual Trajectories of Central Adiposity Indices Combined With Glucose for Cardiovascular Diseases
par: Gangjiao Zhu, et autres
Publié: (2025)

Effects of Dapagliflozin on Cardiovascular Outcomes in Patients With Type 2 Diabetes at Risk of Liver Fibrosis
par: Jan Oscarsson, et autres
Publié: (2026)